Research
Hormonal
CCK-A by itself does not have a central role in long-term energy balance.
This suggests that targeting CCK-A alone may not be effective for weight management strategies.
StrongRefutesmedium confidence
CCK-A by itself does not have a central role in long-term energy balance.
Why this rating
Based on the randomized controlled trial design with a large sample size.
Source
Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients
Jens Jordan et al. · Clinical Pharmacology & Therapeutics · 2007
DOI 10.1038/sj.clpt.6100272
rct · n=701Cited 118×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →